Part 7 of The State of DHCW. Level 4 is intervention, not monitoring: an 8–12 week independent ISRT review of programme management, governance, culture and leadership, reporting roughly September–October 2026. DHCW is the only NHS Wales trust or special health authority above Level 1, and its whole-organisation escalation is matched only by Cardiff and Vale and exceeded only by Betsi Cadwaladr in special measures. Precedent suggests years, not months — and five tests will show whether Phase 1 reaches causes or restates symptoms.
Part 7 of The State of DHCW. Numbered citations resolve at the sources page.
Level 4 is not monitoring — it is intervention. The Welsh Government has commissioned NHS Wales Performance and Improvement’s Intensive Support, Recovery and Turnaround (ISRT) function to assess three things: “adequacy of current actions,” “underlying root causes,” and “required scale and pace of improvement.”[1] This part sets out what that process is, where DHCW sits relative to the rest of NHS Wales, and what the precedent suggests.
The mechanism
| Element | What the framework specifies |
|---|---|
| Phase 1 — Evaluative | An independent review of "the underlying causes of the areas of escalation and challenge with a specific focus on programme management, governance, organisational culture and leadership"; plus "a view on the validity and likely efficacy of the established improvement plans"; plus "an outline of the approach to a phase 2 intervention programme."[1] |
| Who conducts it | "independent and suitably skilled individuals with senior operational and executive experience background to support understanding of the underlying cultural dynamics within the organisation."[1] Note the emphasis: this is framed as a culture diagnostic, not a technical audit. |
| Duration | "around 8 to 12 weeks."[1] The framework was published 9 July 2026, so on that timetable Phase 1 reports roughly September–October 2026. |
| Phase 2 — Delivery | "Terms of reference for the delivery phase will be agreed following the outputs of Phase 1."[1] The scope of the actual intervention is therefore undetermined. |
| Oversight | An Escalation Board chaired by the NHS Wales Chief Executive and Director General for Health, Care and Prevention; ministerial oversight; monthly performance and delivery reviews.[1] Level decisions themselves are taken at joint meetings held "at least twice a year" between Welsh Government, Audit Wales and Healthcare Inspectorate Wales, assessing domains including "leadership, capability and culture."[86] |
| Exit | De-escalation "occurs 1 level at a time" and "requires sustained progress over 2 consecutive quarters."[1] |
Where DHCW actually sits
This is the context most easily missed, and it is stark. On the Welsh Government’s published escalation status list, every other national NHS Wales body is at Level 1:[86]
| Non-health-board NHS Wales organisation | Escalation level |
|---|---|
| Public Health Wales NHS Trust | Level 1 |
| Velindre University NHS Trust | Level 1 |
| Welsh Ambulance Services NHS Trust | Level 1 |
| Health Education and Improvement Wales | Level 1 |
| Digital Health and Care Wales | Level 4 |
DHCW is the only trust or special health authority in Wales above routine monitoring. Health boards are variously escalated, but almost always for specific domains — finance, urgent and emergency care, planned care. DHCW’s Level 4 is for the whole organisation, a breadth matched only by Cardiff and Vale UHB and exceeded only by Betsi Cadwaladr UHB at Level 5.[86] For a national digital body with no hospitals, no waiting lists and no emergency department, that is a remarkable position to occupy.
What the precedent suggests
- Expect years, not months. Betsi Cadwaladr has been at Level 5 since February 2023 — three and a half years.[86] Cardiff and Vale has held whole-organisation Level 4 since July 2025 without movement.[87] With de-escalation moving one level at a time on two consecutive quarters of evidence, the earliest realistic return to Level 3 is mid-2027, and that assumes Phase 2 goes well.
- But domain de-escalation can be quick — when the domain is measurable. Between March and July 2025 Aneurin Bevan moved from Level 4 to Level 3 on finance, and Cwm Taf Morgannwg from Level 3 to Level 1 on finance.[87] That is the encouraging precedent, and also the warning: those are numeric domains. DHCW’s de-escalation criteria are largely qualitative — “governance maturity,” “delivery confidence,” “improved stakeholder confidence,” “reduced key-person dependency”[1] — and are far harder to evidence than a balanced budget.
- Phase 1 will judge DHCW’s own recovery plan, which is already in limbo. The framework asks for “a view on the validity and likely efficacy of the established improvement plans.”[1] DHCW’s Phase 2 escalation plan “had been developed, but its status is currently paused pending the introduction of a revised escalation framework.”[72] So the plan being assessed is itself suspended.
- Expect the findings to surface obliquely rather than be published. The Level 4 framework appeared on gov.wales in July 2026 with no accompanying announcement, and no press coverage of it was traceable at the end of that month; the Auditor General’s remit-letter review, begun September 2025, has produced no published output;[12] and the Limited Assurance recruitment audit was never published.[40] The likeliest route by which Phase 1’s conclusions become visible is a committee highlight report or a private-session summary in DHCW’s own board papers — not a published review.
- The intervention arrives when DHCW is least able to resource it. Welsh Government’s own finding is that “enhanced monitoring and escalation activity absorbed senior and specialist capacity, reducing the organisation’s ability to proactively support recovery in other at-risk programmes.”[1] Layer on the 2026 recruitment pause and the DPIF pause and review[72] and the intervention lands on an organisation that is simultaneously frozen from hiring and uncertain of its programme funding.
- If it fails, Level 5 is a different order of thing. Level 5 engages powers under the NHS (Wales) Act 2006 and “may include providing targeted support, suspending or removing powers and duties from individual or all members of the NHS organisation’s board.”[86]
Five tests to apply to Phase 1 when it lands
The value of the Phase 1 report will lie less in whether it is critical — it will be — than in whether it reaches the causes documented across this record. Five questions discriminate a real diagnosis from a restatement of symptoms:
- Does it examine sequencing, or only delivery discipline? The central failure identified in Part 2 is that six national application programmes were run before the integration layer and architecture that had to carry them. A review that recommends better milestone tracking without addressing build-order has diagnosed the symptom.
- Does it address the authority gap, or treat the problem as internal to DHCW? DHCW cannot compel adoption, sequencing or local testing capacity (Part 6). The Welsh Government’s own de-escalation criteria already gesture at this by requiring “less reliance on Welsh Government brokerage.”[1] If Phase 1 locates all causes inside DHCW, it will have exonerated the commissioning model that produced them.
- Does it test board technical capability? The only published skills review looked for clinical experience and rated the gap “relatively low risk.”[13] There is no technology executive among DHCW’s senior managers (Part 6). A culture-focused review that does not ask who at board level owns architecture will miss the mechanism by which optimism survives.
- Does it ask why the previous reviews failed? DHCW has already had an independent culture review (2024), a 15-recommendation culture and wellbeing review (2025), and a change-management thematic review that found the root cause “had yet to be thoroughly examined.”[60][62][71] A fourth review that does not explain the failure of the first three is likely to share their fate.
- Does it hear from staff, and can it? With confidence that concerns will be addressed at 59.2% and those feeling safe to speak up at 62.8%,[64] a reviewer relying on internally-arranged interviews faces the precise problem the 2018 Public Accounts Committee hit, when it found witnesses “reluctant to be critical … on the record” and evidence that read as “a pre-prepared line.”[21] How Phase 1 collects testimony will largely determine whether it learns anything new.
Expectation. Phase 1 will almost certainly confirm the escalation, criticise programme management and delivery culture, and validate parts of DHCW's improvement plan while finding it insufficient. That much is safe to predict from the framework's own framing, which pre-commits the reviewers to a focus on "cultural dynamics."
The open question is whether it reaches the two structural causes — build-order and authority — that sit beneath the behavioural findings. A review scoped to organisational culture and led by people with "senior operational and executive experience" may be well equipped to diagnose optimism bias and poor grip, and poorly equipped to judge whether Wales sequenced its national digital programme correctly, or whether a body without directive power over its adopters can ever be held solely accountable for their adoption. On the record of the 2018 reboot and the 2021 reorganisation, that is the recurring failure mode: each intervention correctly identifies how the organisation behaves, and leaves untouched the structure that makes it behave that way.
What to watch next
- The ISRT Phase 1 report (due roughly September–October 2026 on the published 8–12 week timetable). Its key test: whether it treats the causes as internal to DHCW or systemic to NHS Wales digital governance.[1]
- Substantive chair appointment. DHCW entered Level 4 with an interim chair and an interim finance director.[38] Whether the Welsh Government appoints a substantive chair before or after Phase 1 reports will signal whether it expects leadership change.
- The Auditor General’s remit-letter review, begun September 2025, whose outcome had not been published as at compilation.[12]
- LIMS 2.0 Blood Transfusion and Blood Sciences. Both had completion dates “under review” in January 2026,[4] against a health board warning about pathology service continuity if the legacy system reaches end of life first.[51] This is the highest clinical-risk item in the portfolio.
- The promised ten-year Digital and Data Strategy and “road map of a single integrated patient record” under the new Welsh Government.[29][10] Whether it revisits DHCW’s mandate and powers — rather than only its plan — is the substantive question. The six tests for that announcement are set out here.
- Seventh Senedd scrutiny. No DHCW-specific committee inquiry had been established as at compilation; Senedd Research has flagged digital delivery as a key issue for the term.[26]
- The employment tribunal register. No judgment involving DHCW appears on the gov.uk employment tribunal decisions register as at 30 July 2026. Because judgments publish only on hand-down and daily hearing lists are not archived (see Part 3), this is the single most likely source of a step-change in the documented record on culture, speaking up and the treatment of technical dissent — and it would arrive without warning. The register should be checked periodically against “Digital Health and Care Wales.”[85]